Transcriptome profiling revealed that PDE4B mRNA expression levels in blood were lower in PTSD patients than those in controls and significantly correlated with the severity of re-experiencing symptoms and trait anxiety and with PDE4B DNA methylation levels (Hori et al., 2024). This evidence concerns the gene PDE4B and post-traumatic stress disorder.